Code | 4268D | ||||||||||
MA number | EU/1/19/1419/004 | ||||||||||
Product Form: | sol inf 1x10 ml/100 mg (liek.inj.skl.) | ||||||||||
MA Status: | E - Valid centralised marketing authorisation | ||||||||||
Type of procedure: | EU Orphan | ||||||||||
MAH, country: | SciPharm Sárl, Luxembourg | ||||||||||
Therapeutic Class: | 16 - ANTICOAGULANTIA (FIBRINOLYTICA, ANTIFIBRINOL.) | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 36 | ||||||||||
Container: | glass vial | ||||||||||
Route of admin.: | Subcutaneous use |
Prescription Status: | Medicinal product subject to restricted medical prescription. |
Legal basis: | Article 10(3) hybrid application |
MA issued: | 03.04.2020 |
SmPC + PL: |
|
Safety feature | Yes |
Data update: | 08.01.2025 |